Suppr超能文献

一项关于特发性扩张型心肌病中柯萨奇B病毒抗体的前瞻性病例对照研究。

A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy.

作者信息

Keeling P J, Lukaszyk A, Poloniecki J, Caforio A L, Davies M J, Booth J C, McKenna W J

机构信息

Department of Cardiological Sciences, St. George's Hospital Medical School, London, England, United Kingdom.

出版信息

J Am Coll Cardiol. 1994 Mar 1;23(3):593-8. doi: 10.1016/0735-1097(94)90742-0.

Abstract

OBJECTIVES

This study was conducted to determine the frequency and significance of Coxsackie B virus-specific immunoglobulin-M (IgM) in patients with idiopathic dilated cardiomyopathy and compare them with the frequency in both unmatched and matched control subjects.

BACKGROUND

The principal evidence supporting a pathoetiologic role for Coxsackie B viruses in human dilated cardiomyopathy is derived from retrospective serologic studies. These studies have evaluated patients with end-stage disease and have failed to recognize the importance of assessing both matched and unmatched control subjects.

METHODS

In this prospective case-control study, we assessed sera for Coxsackie B virus-specific IgM (serotypes B1 to B5) from 114 patients with dilated cardiomyopathy at diagnosis or referral to our center, 94 healthy unmatched control subjects, 41 healthy matched control subjects from the same general practitioner and 32 members of the patients' own households.

RESULTS

A higher frequency of positive Coxsackie B virus IgM was observed in patients with dilated cardiomyopathy than in unmatched control subjects (33% vs. 5%; p = 3 x 10(-7)). In patients with dilated cardiomyopathy, the response was monotypic (84%), commonly against serotypes B2 and B5, and was not associated with any clinical or histologic feature. The frequency of positive virus-specific IgM was similar in patients with dilated cardiomyopathy and their 41 matched community control subjects (46% vs. 27%; p = 0.11) and 32 household contacts (37% vs. 28%; p = 0.59). Control subjects who tested positive for virus-specific IgM tended more commonly to be seropositive than did control seronegative subjects (community control subjects 37% vs. 18%, p = 0.32; household contacts 42% vs. 20%; p = 0.36) and had an identical serotypic response in 4 (33%) of 12 cases.

CONCLUSIONS

The frequency of Coxsackie B virus IgM was higher in patients with dilated cardiomyopathy than in unmatched control subjects but was similar in patients and control subjects who shared the same environment, indicating local spread of infection. The reason for the association between Coxsackie B virus IgM and dilated cardiomyopathy and its relevance to pathogenesis remain to be established.

摘要

目的

本研究旨在确定柯萨奇B病毒特异性免疫球蛋白M(IgM)在特发性扩张型心肌病患者中的出现频率及意义,并将其与未匹配和匹配的对照受试者中的频率进行比较。

背景

支持柯萨奇B病毒在人类扩张型心肌病中起病原学作用的主要证据来自回顾性血清学研究。这些研究评估的是终末期疾病患者,未认识到评估匹配和未匹配对照受试者的重要性。

方法

在这项前瞻性病例对照研究中,我们检测了114例诊断时或转诊至本中心的扩张型心肌病患者、94名健康未匹配对照受试者、41名来自同一名全科医生的健康匹配对照受试者以及32名患者家庭成员的血清中柯萨奇B病毒特异性IgM(B1至B5型)。

结果

扩张型心肌病患者中柯萨奇B病毒IgM阳性频率高于未匹配对照受试者(33%对5%;p = 3×10⁻⁷)。在扩张型心肌病患者中,反应为单型(84%),通常针对B2和B5型,且与任何临床或组织学特征均无关联。扩张型心肌病患者与其41名匹配的社区对照受试者(46%对27%;p = 0.11)以及32名家庭成员(37%对28%;p = 0.59)中病毒特异性IgM阳性频率相似。病毒特异性IgM检测呈阳性的对照受试者血清阳性的倾向比血清阴性对照受试者更常见(社区对照受试者37%对18%,p = 0.32;家庭成员42%对20%;p = 0.36),并且在12例中的4例(33%)中具有相同的血清型反应。

结论

扩张型心肌病患者中柯萨奇B病毒IgM频率高于未匹配对照受试者,但在共享相同环境的患者和对照受试者中相似,表明存在局部感染传播。柯萨奇B病毒IgM与扩张型心肌病之间关联的原因及其与发病机制的相关性仍有待确定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验